Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN vs MICAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASPOFUNGIN vs MICAFUNGIN: Safety Overview

Metric CASPOFUNGIN MICAFUNGIN
Total FAERS Reports 3,814 3,117
Deaths Reported 1,419 1,068
Death Rate 37.2% 34.3%
Hospitalizations 1,638 1,121
Average Patient Age 47.5 yrs 49.7 yrs
% Female Patients 42.8% 38.7%
FDA Approval Date Dec 30, 2016 Apr 3, 2025
Manufacturer Sandoz Inc Zydus Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued